LLY Stock Alert: Why Are Eli Lilly Shares Surging Today?

Eli Lilly (NYSE:LLY) stock rose 13% overnight after it beat analyst estimates and raised guidance. The company’s GLP-1 drugs for diabetes and weight loss, Zepbound and Mounjaro, propelled the results.The company reported net income of $2.97 billion, $3.28 per share fully diluted, on revenue of $11.3 billion. Lilly also raised its full-year revenue guidance to $45.4 billion-$46.6 billion and earnings per share guidance to $15.10-$15.40 per share. The market responded as if Lilly was selling artificial intell ...